Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial

…, MM Richter, M Schulz, S Unterecker… - The British Journal of …, 2007 - cambridge.org
BackgroundRepetitive transcranial magnetic stimulation (rTMS) has been proposed as a new
treatment option for depression. Previous studies were performed with low sample sizes in …

Reduction of skin innervation is associated with a severe fibromyalgia phenotype

…, J Frank, A Klitsch, S Unterecker… - Annals of …, 2019 - Wiley Online Library
Objective To assess patterns and impact of small nerve fiber dysfunction and pathology in
patients with fibromyalgia syndrome (FMS). Methods One hundred seventeen women with …

TDM in psychiatry and neurology: a comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; …

G Schoretsanitis, M Paulzen, S Unterecker… - The world journal of …, 2018 - Taylor & Francis
Objectives: Therapeutic drug monitoring (TDM) combines the quantification of drug concentrations
in blood, pharmacological interpretation and treatment guidance. TDM introduces a …

[HTML][HTML] Classification of advanced stages of Parkinson's disease: translation into stratified treatments

…, D Weiss, L Tönges, P Kolber, S Unterecker… - Journal of Neural …, 2017 - Springer
Advanced stages of Parkinson’s disease (advPD) still impose a challenge in terms of
classification and related stage-adapted treatment recommendations. Previous concepts that …

Reduced response-inhibition in obsessive–compulsive disorder measured with topographic evoked potential mapping

MJ Herrmann, C Jacob, S Unterecker, AJ Fallgatter - Psychiatry research, 2003 - Elsevier
Recent neuroimaging studies have suggested that a hyperactivity of the frontal-striate
neuronal circuits, including the orbitofrontal cortex and the basal ganglia, mediates the …

Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels

G Hefner, MEE Shams, S Unterecker, T Falter… - …, 2016 - Springer
Rationale In psychiatric clinical practice, there is a need to identify psychotropic drugs whose
metabolisms are prone to be altered with increased inflammatory activity in an individual …

[HTML][HTML] Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort …

…, A Frantz, A Eckert, H Weber, S Unterecker… - International Journal of …, 2023 - Springer
Background Pharmacogenetics (PGx), especially in regard to CYP2D6, is gaining more
importance in routine clinical settings. Including phenoconversion effects (PC) in result …

[HTML][HTML] Effects of pharmacokinetic gene variation on therapeutic drug levels and antidepressant treatment response

…, S Stonawski, L Hommers, S Unterecker… - …, 2022 - thieme-connect.com
Introduction Pharmacogenetic testing is proposed to minimize adverse effects when considered
in combination with pharmacological knowledge of the drug. As yet, limited studies in …

[HTML][HTML] Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive …

…, U Malzahn, P Heuschmann, S Unterecker… - Comprehensive …, 2022 - Elsevier
Background Sertraline is a selective serotonin reuptake inhibitor with specific indications in
child and adolescent psychiatry. Notwithstanding its frequent use and clinical benefits, the …

[HTML][HTML] Serious adverse drug reactions in children and adolescents treated on-and off-label with antidepressants and antipsychotics in clinical practice

…, U Malzahn, P Heuschmann, S Unterecker… - …, 2022 - thieme-connect.com
Introduction Despite the growing evidence base for psychotropic drug treatment in pediatric
patients, knowledge about the benefit-risk ratio in clinical practice remains limited. The ‘…